Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-22-022527
Filing Date
2022-06-06
Accepted
2022-06-06 06:03:34
Documents
13
Period of Report
2022-05-27
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A txmd-8ka_20220527.htm   iXBRL 8-K/A 36261
2 EX-3.1 txmd-ex31_6.htm EX-3.1 7759
  Complete submission text file 0001564590-22-022527.txt   183524

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA txmd-20220527.xsd EX-101.SCH 5613
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20220527_lab.xml EX-101.LAB 20772
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20220527_pre.xml EX-101.PRE 12388
7 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8ka_20220527_htm.xml XML 4314
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-00100 | Film No.: 22996625
SIC: 2834 Pharmaceutical Preparations